3D bioprinting and scaffold-free strategies for fabrication of multi-cellular tissues or organoids

被引:3
|
作者
Li, Haoyu [1 ]
Zhou, Huixing [1 ]
Xu, Chongwen [1 ]
Wei, Yen [2 ,3 ]
Tang, Xiuying [4 ]
机构
[1] Beijing Univ Civil Engn & Architecture, Sch Mech Elect & Vehicle Engn, Beijing 100044, Peoples R China
[2] Tsinghua Univ, Minist Educ, Dept Chem, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[3] Tsinghua Univ, Tsinghua Ctr Frontier Polymer Res, Beijing 100084, Peoples R China
[4] China Agr Univ, Coll Engn, Beijing 100083, Peoples R China
关键词
Multi-cellular tissues or organoids (MTOs); Biofabrication strategies; Scaffold-based and scaffold-free strategies; 3D bioprinting; Bioassembly; BioMicroMesh; MICROTISSUES; MODEL; BONE;
D O I
10.36922/ijb.0135
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The biofabrication of multi-cellular tissues or organoids (MTOs) has been challenging in regenerative medicine for decades. Currently, two primary technological approaches are being explored: scaffold-based strategies utilizing three-dimensional (3D) bioprinting techniques and scaffold-free strategies employing bioassembly techniques. 3D bioprinting techniques include jetting-based, extrusion-based, and vat photopolymerization-based methods, and bioassembly techniques include Kenzan, fluid-based manipulation and microfluid, bioprinting-assisted tissue emergence, and aspiration-assisted technology methods. Scaffold-based strategies primarily concentrate on the construction of scaffold structures to provide an extracellular environment, while scaffold-free strategies primarily emphasize the assembly methods of building blocks. Different biofabrication technologies have their advantages and limitations. This review provides an overview of the mechanisms, advantages, and limitations of scaffold-based and scaffold-free strategies in tissue engineering. It also compares the strengths and weaknesses of these two strategies, along with their respective suitability under different conditions. Moreover, the significant challenges in the future development of convergence strategies, specifically the integration of scaffold-based and scaffold-free approaches, are examined in an objective manner. This review concludes that integrating scaffold-based and scaffold-free strategies could overcome the problems in the biofabrication of MTOs. A novel fabrication method, the BioMicroMesh method, is proposed based on the convergence strategy. Concurrently, the development of a desktop-scale integrated intelligent biofabrication device, the BioMicroMesh system, is underway. This system is tailored to the BioMicroMesh method and incorporates cell aggregate spheroids preparation, 3D bioprinting, bioassembly, and multi-organoid co-culture functions, providing an objective perspective on its capabilities.
引用
收藏
页码:200 / 221
页数:22
相关论文
共 50 条
  • [21] Scaffold-free 3D-bioprinting (3DBP) of the liver and its continuous perfusion with the bioreactor
    Li, P.
    Smith, L. J.
    Vega, C.
    Ekser, B.
    TRANSPLANTATION, 2018, 102 : 74 - 75
  • [22] Scaffold-free 3D-bioprinting (3DBP) of genetically-engineered pig cells
    Li, Ping
    Smith, Lester J.
    Butler, James R.
    Irwin, Stephanie T.
    Kubal, Chandrashekhar A.
    Fridell, Jonathan A.
    Ekser, Burcin
    XENOTRANSPLANTATION, 2017, 24 (05)
  • [23] MODELLING OSTEOARTHRITIS IN VITRO - APPLICABILITY OF 3D SCAFFOLD-FREE CONSTRUCTS
    Lang, A.
    Neuhaus, J.
    Barnewitz, D.
    Gaber, T.
    Ponomarev, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 919 - 920
  • [24] Scaffold-free and scaffold-based cellular strategies and opportunities for cornea tissue engineering
    Hussain, Zahid
    Pei, Renjun
    PROGRESS IN BIOMEDICAL ENGINEERING, 2021, 3 (03):
  • [25] 3D Analysis of Multi-cellular Responses to Chemoattractant Gradients
    Kang, Tae-Yun
    Ellison, David
    Lee, Sung Hoon
    Ewald, Andrew J.
    Levchenko, Andre
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (147):
  • [26] BIOFABRICATION OF SCAFFOLD-FREE 3D CELLULAR STRUCTURES USING MAGNETIC LEVITATIONAL ASSEMBLY TO STUDY CARDIAC TOXICITY
    Onbas, Rabia
    Yildiz, Ahu Arslan
    TISSUE ENGINEERING PART A, 2023, 29 (11-12) : 232 - 232
  • [27] 3D Models and Multi-Organ-Chips: Scaffold-free 3D tissue models - from static to microphysiological applications
    Frey, O.
    Thoma, E.
    Yesildag, B.
    Wolf, A.
    Lichtenberg, J.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (SUPPL 1) : S37 - S37
  • [28] 3D Bioprinting Strategies for the Regeneration of Functional Tubular Tissues and Organs
    Jeong, Hun-Jin
    Nam, Hyoryung
    Jang, Jinah
    Lee, Seung-Jae
    BIOENGINEERING-BASEL, 2020, 7 (02):
  • [29] 3D bioprinting of tissues and organs
    Sean V Murphy
    Anthony Atala
    Nature Biotechnology, 2014, 32 : 773 - 785
  • [30] High-throughput scaffold-free microtissues through 3D printing
    Christen J. Boyer
    David H. Ballard
    Mansoureh Barzegar
    J. Winny Yun
    Jennifer E. Woerner
    Ghali E. Ghali
    Moheb Boktor
    Yuping Wang
    J. Steven Alexander
    3D Printing in Medicine, 4 (1)